Seventy-three patients who experienced acute uncomplicated lower urinary tract infections with mainly gram negative becteria received a single dose 200mg ofloxacin treatment. Urinary leukocyte count returned to normal level in 65.1% of the patients three day after drug administration. Patients with significant bacteriuria achieved the best result (sure rate 75%). Age and severity of pyuria had no significant influence on the result. Adverse drug reaction, with G-I upset the predominant discomfort, occurred for 9.09% of the patients. Compared with traditional long term (7-14days) or short duration (1-3 days) treatment, single dose therapy has the following advantages: (1)lower cost; (2) less chance of inducing resistant strain microorganism; (3) fewer side effect; (4)better patient compliance. It would be worthwhile to undertake extensive study of clinical applications especially in Taiwan where the medical budget is rising and bacterial resistant strains are common.
Seventy-three patients who experienced acute uncomplicated lower urinary tract infections with mainly gram negative becteria received a single dose 200mg ofloxacin treatment. Urinary leukocyte count returned to normal level in 65.1% of the patients three day after drug administration. Patients with significant bacteriuria achieved the best result (sure rate 75%). Age and severity of pyuria had no significant influence on the result. Adverse drug reaction, with G-I upset the predominant discomfort, occurred for 9.09% of the patients. Compared with traditional long term (7-14days) or short duration (1-3 days) treatment, single dose therapy has the following advantages: (1)lower cost; (2) less chance of inducing resistant strain microorganism; (3) fewer side effect; (4)better patient compliance. It would be worthwhile to undertake extensive study of clinical applications especially in Taiwan where the medical budget is rising and bacterial resistant strains are common.